Trial Profile
A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Moderate to Severe Dry Eye Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Dec 2016
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Registrational; Therapeutic Use
- Sponsors Santen S.A.S.
- 21 May 2014 New trial record